Clinical Trial Update: Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled trial assessing efficacy and safety of GW876008 in irritable bowel syndrome has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• GW876008

Snippet

Sponsor: GlaxoSmithKline | Conditions: Irritable Bowel Syndrome (IBS) | Phase 2 | Status: COMPLETED | Results posted: 2017-12-26